ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,492Medicare Part D Prescriptions Filled, Including Refills

Rank: 393 out of 6969

$457K Total Retail Price of All Prescriptions

Rank: 735 out of 6969

307 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 307 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

30% of this provider’s 307 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 7,971 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 395 282 S3 1 3
LISINOPRIL 392 307 2 2
FUROSEMIDE 345 294 3 10
OMEPRAZOLE 339 251 4 6
PRAVASTATIN SODIUM 268 224 5 19
WARFARIN SODIUM 268 268 5 20
SIMVASTATIN 256 189 7 1
METFORMIN HCL 239 186 8 7
MELOXICAM 237 175 9 36
DONEPEZIL HCL 218 218 10 32
TRAMADOL HCL 215 155 11 27
CARVEDILOL 211 168 12 25
ATORVASTATIN CALCIUM 188 136 13 11
TRAZODONE HCL 185 118 14 47
GABAPENTIN 174 145 15 17
ALENDRONATE SODIUM 169 141 16 14
LEVOTHYROXINE SODIUM 157 105 17 5
SERTRALINE HCL 153 111 18 38
ATENOLOL 149 134 19 9
AMLODIPINE BESYLATE 144 126 20 4
RANITIDINE HCL 136 120 21 46
JANUVIA 123 92 22 41
NAMENDA 112 112 23 51
KLOR-CON 8 110 103 24 104
HYDROCHLOROTHIAZIDE 93 69 25 8
ISOSORBIDE MONONITRATE ER 92 53 26 81
TAMSULOSIN HCL 85 69 27 23
METHOCARBAMOL 83 52 R 28 249
RISPERIDONE 79 51 29 88
PANTOPRAZOLE SODIUM 78 42 30 31
BENAZEPRIL HCL 78 50 30 18
OXYBUTYNIN CHLORIDE 77 70 32 126
SINGULAIR 76 54 33 84
POTASSIUM CHLORIDE 75 74 34 30
CARISOPRODOL 74 31 R 35 69
BACLOFEN 73 69 36 86
ESCITALOPRAM OXALATE 72 52 37 93
TRICOR 71 53 38 143
CLOPIDOGREL 70 50 39 48
MONTELUKAST SODIUM 68 54 40 151
LACTULOSE 66 51 41 131
LOSARTAN POTASSIUM 66 65 41 12
METOPROLOL TARTRATE 64 32 43 13
CARBIDOPA-LEVODOPA 63 53 44 119
BUMETANIDE 63 57 44 305
TERAZOSIN HCL 63 63 44 49
NEXIUM 62 19 47 52
ALLOPURINOL 60 51 48 35
MEGESTROL ACETATE 56 43 R 49 129
FAMOTIDINE 55 45 50 37
PLAVIX 55 44 50 68
DIOVAN 55 52 50 26
COMBIVENT 55 31 50 170
NORTRIPTYLINE HCL 53 35 54 140
GLIPIZIDE 53 48 54 21
FLUOXETINE HCL 50 49 56 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.